Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
- 1 July 1998
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 37 (7) , 953-955
- https://doi.org/10.1016/s0028-3908(98)00078-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Novel Agonists of 5HT2C Receptors. Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive DisorderJournal of Medicinal Chemistry, 1997
- SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor AntagonistNeuropharmacology, 1997
- 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonistsEuropean Journal of Pharmacology, 1997
- Dopamine, the prefrontal cortex and schizophreniaJournal of Psychopharmacology, 1997
- Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitroBrain Research, 1994
- Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortexPsychopharmacology, 1994
- Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?Psychopharmacology, 1994
- Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptorsMolecular Brain Research, 1994